PerrigoPRGO
PRGO
About: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Employees: 8,379
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
295% more call options, than puts
Call options by funds: $53.3M | Put options by funds: $13.5M
21% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 113
9% more funds holding in top 10
Funds holding in top 10: 11 [Q4 2024] → 12 (+1) [Q1 2025]
9% more capital invested
Capital invested by funds: $3.45B [Q4 2024] → $3.75B (+$306M) [Q1 2025]
0.1% less ownership
Funds ownership: 98.19% [Q4 2024] → 98.09% (-0.1%) [Q1 2025]
3% less funds holding
Funds holding: 353 [Q4 2024] → 342 (-11) [Q1 2025]
14% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 51
Research analyst outlook
We haven’t received any recent analyst ratings for PRGO.
Financial journalist opinion
Based on 9 articles about PRGO published over the past 30 days
Neutral
PRNewsWire
22 hours ago
Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference
DUBLIN , July 29, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Canaccord Genuity 45th Annual Growth Conference, on Tuesday, August 12 th at 9:00 AM EDT. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
Positive
Zacks Investment Research
4 days ago
Is Perrigo (PRGO) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
PRNewsWire
6 days ago
Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025
DUBLIN , July 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its second quarter 2025 financial results on Wednesday, August 6 th, 2025, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 800-836-8184, International 646-357-8785, and reference ID # 45051.
Positive
Zacks Investment Research
1 week ago
Wall Street Analysts Believe Perrigo (PRGO) Could Rally 35.36%: Here's is How to Trade
The mean of analysts' price targets for Perrigo (PRGO) points to a 35.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Positive
Zacks Investment Research
1 week ago
Why Perrigo (PRGO) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
PRNewsWire
2 weeks ago
Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million
Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfront Cash and Up to €27 Million in Potential Future Milestone Payments Expected Net Proceeds to be Directed Towards Previously Announced Capital Allocation Priorities, Including Further Strengthening the Company's Balance Sheet DUBLIN , July 14, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading global provider of Consumer Self-Care Products, today announced it has signed an agreement with Kairos Bidco AB, an investment vehicle managed by KKR, a leading global investment firm, to sell the Company's Dermacosmetics branded business for up to €327 million, including €300 million in upfront cash and up to an additional €27 million contingent on the achievement of net sales milestones over the next three years. This transaction advances the Company's Three-S plan to Stabilize, Streamline and Strengthen the organization, honing its strategic focus to invest in its 'high-grow', high-return opportunities.
Positive
Zacks Investment Research
2 weeks ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
PRNewsWire
4 weeks ago
Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance
Company to Scale and Optimize Global Category-Led, Market Activation Growth Model Roberto Khoury, EVP & President Consumer Self-Care International (CSCI), Appointed to New Position of EVP & Chief Commercial Officer to Lead Global Market Activation Triona Schmelter, EVP & President Consumer Self-Care Americas (CSCA), to Leave Organization DUBLIN , July 1, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that it is scaling and optimizing its proven growth model—anchored in global Category Leadership and Market Activation—across the organization to enhance agility, accelerate innovation, and drive long-term sustainable growth. This organizational alignment advances Perrigo's multi-year Stabilize, Streamline and Strengthen ('Three-S') plan and reflects operational readiness across the Company.
Neutral
PRNewsWire
4 weeks ago
Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby
Beginning July 1, 2025, a month-long giveaway contest will award 100 winners with two months' worth of Good Start® | Dr. Brown's™ Gentle Pro™ baby formula plus Dr. Brown's products (valued at $516.49) – and support families in need with a donation of formula to Baby2Baby that exceeds the total contest value GRAND RAPIDS, Mich. , July 1, 2025 /PRNewswire/ -- Today, the makers of Good Start® | Dr. Brown's™ infant formula announced a nationwide giveaway contest to support families across the country.
Positive
Zacks Investment Research
1 month ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Charts implemented using Lightweight Charts™